{
  "docId": "019de077-19d1-772e-933a-c7f1c42d9b04",
  "docSlug": "d223628377f56d072b5dbf426c21baf1",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 42 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 42,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a timeline-based structure to demonstrate historical progress and future financial stability.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-19d1-772e-933a-c7f1c42d9b04/5",
  "deckHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04",
  "deckJsonHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04.json",
  "deckAnchorHref": "/decks/019de077-19d1-772e-933a-c7f1c42d9b04#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.94,
        "x": 0.03,
        "y": 0.206
      },
      "kind": "callout",
      "text": "Resource-efficient execution and value creation across an expanding portfolio of wholly-owned programs",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a0a85f7e-f4eb-48fa-8dbc-1d08c7ca0f30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.66,
        "y": 0.36
      },
      "kind": "list",
      "text": "2023: SECOND PROOF-OF-CONCEPT & FIRST PIVOTAL STUDY. Demonstrated clinical proof-of-concept for ALK program, Initiated ARROS-1 Phase 2, Advanced HER2 program towards IND",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3506d2fe-57e4-4b1a-9903-3410c5be2ce5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.36,
        "y": 0.36
      },
      "kind": "list",
      "text": "2022: FIRST CLINICAL PROOF-OF-CONCEPT. Initiated two global Phase 1/2 studies, Demonstrated clinical proof-of-concept for ROS1 program, Disclosed third novel program",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0402f36-25af-48bb-94ab-f491ff497b77",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.28,
        "x": 0.06,
        "y": 0.36
      },
      "kind": "list",
      "text": "2021: EMERGENCE FROM STEALTH. Disclosed parallel lead programs (ROS1+ and ALK+ NSCLC), Presented preclinical profiles, Nasdaq listed: NUVL",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1ad998d-930a-4b34-893f-0c91d0767e7d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.6,
        "x": 0.2,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "Ended 2023 with $719.9M in cash, cash equivalents and marketable securities, with potential to deliver multiple transformative catalysts within cash runway window into 2027",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "af1b1de6-1f94-47d4-8c1e-45ff0c54c528",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.36,
        "x": 0.32,
        "y": 0.1
      },
      "kind": "title",
      "text": "Track Record of Success",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ccf0ed29-68ae-4be2-9c95-01a899fb4989",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "3cad87f8-e3af-4d10-93a7-2133726bd83c",
      "evidence": "Chronological presentation of milestones from 2021-2023",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 5,
      "beatId": "2dcda6c1-3484-4532-aee0-926623f1c867",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "The deck presents Nuvalent's track record of success",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}